BIRC5 and cancer: The excised cancer tissue of the patients receiving BRB revealed significant reduction of expression of genes encoding proteins, important for the survival of cancer cells (AURKA, EGFR, or BIRC5), as well as proinflammatory agents NFKB1, PTGS2, whose expression in OSCC cells is substantially exceeded.